The complexities of Congenital Heart Disease (CHD), known in Indonesia as Penyakit Jantung Bawaan (PJB), remain a significant challenge for the nation’s healthcare system, particularly as the exact etiology of these conditions often remains elusive to medical science. During a comprehensive webinar hosted by the Indonesian Pediatric Society (IDAI) on Tuesday, February 14, 2023, medical experts highlighted the critical intersection between maternal health and neonatal outcomes. Dr. Rizky Adriansyah, MKed, a pediatric specialist and Chairman of the Cardiology Coordination Unit of the IDAI, emphasized that while a direct cause-and-effect relationship is difficult to pinpoint, several preventable risk factors during pregnancy play a decisive role in the development of heart defects in newborns.
Congenital Heart Disease refers to structural problems with the heart that are present at birth. These defects can affect the heart’s walls, valves, or blood vessels, disrupting the normal flow of blood through the organ. As the most common type of birth defect globally, CHD requires a nuanced understanding of prenatal care, early diagnostic interventions, and long-term management strategies to reduce the high mortality rates associated with the condition.
Identifying Key Risk Factors During Pregnancy
According to Dr. Rizky, recent medical literature consistently points to three primary risk factors that pregnant women can actively manage or avoid to mitigate the risk of CHD. While these factors do not guarantee the occurrence of a heart defect, they are statistically significant contributors to disruptions in the fetal heart’s developmental process, which typically occurs within the first eight weeks of pregnancy.
The first major factor is the presence of infections, most notably the Rubella virus. Maternal infection with Rubella, particularly during the first trimester, can lead to Congenital Rubella Syndrome (CRS), of which heart defects are a primary component. The second factor is nutritional deficiency, specifically a lack of folic acid. Folic acid is essential for DNA synthesis and cell growth; a deficiency during the early stages of embryogenesis can lead to various malformations, including neural tube defects and cardiac anomalies. The third factor involves the consumption of certain medications during pregnancy, such as anti-seizure medications (anticonvulsants), which have been documented to interfere with fetal organogenesis.
Dr. Rizky noted that while traditional lifestyle factors such as smoking and alcohol consumption are well-established risks, they do not account for all cases. "Many cases involve mothers who do not smoke or drink alcohol yet still give birth to children with CHD," he explained. This underscores the necessity of a holistic approach to prenatal health that goes beyond avoiding obvious toxins to include proactive nutritional and immunological preparation.
The Statistical Burden of CHD in Indonesia
The impact of CHD on infant mortality in Indonesia is profound. National data from 2017 indicates that CHD is the second largest contributor to neonatal deaths, accounting for 17 percent of fatalities in the first month of life, surpassed only by complications related to prematurity. This statistic highlights a critical public health crisis, as many of these deaths are preventable with timely intervention.
On a global scale, the World Health Organization (WHO) estimates that approximately one out of every 100 newborns suffers from some form of CHD. Within this group, roughly 25 percent are classified as "critical CHD," a condition requiring surgery or catheter intervention within the first year—and often the first days—of life. In the Indonesian context, this translates to an estimated two to four critical CHD cases for every 1,000 live births. Given Indonesia’s high birth rate, the sheer volume of patients requiring specialized cardiac care is immense.
Despite these figures, the treatment gap in Indonesia remains wide. Dr. Rizky revealed that currently, less than 50 percent of CHD cases in the country are handled effectively. This disparity is attributed to a combination of factors, including limited access to specialized cardiac centers, a shortage of diagnostic equipment in rural areas, a lack of specialized human resources—specifically pediatric cardiologists and cardiothoracic surgeons—and a general lack of public awareness regarding the symptoms of heart defects in infants.
Diagnostic Innovations and Early Detection Strategies
One of the primary hurdles in managing CHD in Indonesia is the high rate of late diagnosis. When a heart defect is not identified shortly after birth, the infant’s condition can deteriorate rapidly, leading to irreversible complications or death. Dr. Rizky emphasized that early detection is the only way to improve survival rates, as prevention is no longer an option once the child is born.
The medical community is currently advocating for the widespread use of pulse oximetry screening for all newborns. This method is described as highly sensitive, rapid, and cost-effective. By placing a sensor on the newborn’s right hand and either foot, healthcare providers can measure oxygen saturation levels. A significant difference in oxygen levels or a low overall saturation can serve as an early warning sign of critical CHD, even before physical symptoms become apparent.
In addition to pulse oximetry, the use of a stethoscope remains a fundamental tool. The presence of a heart murmur—an unusual sound heard between heartbeats—should immediately prompt a referral for a more detailed cardiac evaluation. For children exhibiting clinical symptoms, echocardiography (an ultrasound of the heart) remains the gold standard for confirming a diagnosis and determining the specific nature of the defect.
Recognizing Clinical Symptoms in Infants
Parents and primary caregivers play a vital role in the early detection of CHD by monitoring for specific clinical signs. One of the most common indicators is poor weight gain or "failure to thrive." Infants with heart defects often tire easily during feeding, leading to inadequate caloric intake. They may sweat excessively during exertion, such as while breastfeeding, or exhibit rapid, labored breathing.
In more severe or critical cases, symptoms may appear within the first 24 to 48 hours or the first week of life. These can include cyanosis (a bluish tint to the skin, lips, or fingernails caused by low oxygen levels), extreme lethargy, or a weak pulse. Dr. Rizky pointed out that because these symptoms can sometimes be subtle or mistaken for other neonatal issues, education for both parents and frontline healthcare workers is essential.
To facilitate this education, the IDAI has utilized digital platforms, including a YouTube channel titled "Sehatkan Jantung Anak Indonesia" (Healthy Hearts for Indonesian Children). This resource provides visual guides and information on how to recognize symptoms and the steps to take for a medical evaluation.
Strengthening the Role of Frontline Healthcare Workers
A significant portion of births in Indonesia, particularly in rural and sub-urban areas, are attended by midwives and general practitioners. Dr. Rizky highlighted that these healthcare professionals are the first line of defense against CHD. He noted that a basic cardiac screening, including pulse oximetry and physical observation, takes less than five minutes to perform.
If midwives and local health clinics can be empowered and equipped to conduct these screenings routinely, the rate of early detection could see a dramatic increase. The goal is to create a seamless referral pathway where a suspected case at a village level is quickly moved to a regional facility capable of performing echocardiography and, eventually, to a national center for surgical intervention if necessary.
Analysis of Implications and the Path Forward
The findings presented by Dr. Rizky and the IDAI suggest that Indonesia’s approach to CHD must be two-fold: improving maternal health infrastructure and expanding neonatal cardiac screening.
From a policy perspective, the government must prioritize the Rubella vaccination program. Ensuring that young women are immunized before they become pregnant is perhaps the most effective way to reduce the incidence of infection-related heart defects. Furthermore, public health campaigns should emphasize the importance of prenatal vitamins, specifically folic acid, which should ideally be started even before conception.
On the clinical side, the "treatment gap" where 50 percent of cases go unmanaged indicates a need for decentralized cardiac care. Currently, the most advanced cardiac procedures are concentrated in major urban centers like Jakarta. Expanding the capacity of regional hospitals to perform at least basic corrective surgeries and interventional catheterizations would alleviate the burden on national referral centers and save lives by reducing travel time for critically ill infants.
Furthermore, the integration of pulse oximetry into the standard "newborn toolkit" across all Indonesian health facilities is a low-cost intervention with a high return on investment. By identifying critical CHD within the first 48 hours of life, the medical system can intervene before the infant experiences a metabolic collapse, which significantly improves the success rate of subsequent surgeries.
The challenge of Congenital Heart Disease in Indonesia is not merely a medical issue but a systemic one. It requires the synchronization of maternal education, specialized training for healthcare providers, and a robust infrastructure for early diagnosis. As Dr. Rizky Adriansyah concluded, the responsibility for protecting the hearts of the nation’s children lies not just with specialists, but with every level of the healthcare system and the community at large. Through heightened awareness and proactive screening, the goal of reducing neonatal mortality and ensuring a healthier future for Indonesian children remains within reach.
